Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Nia6.0
Niacinamide – Forschung
Überwiegend Mechanismus / Beobachtung
7 begutachtete Studien
Was die Evidenz sagt
Überwiegend Mechanismus / Beobachtung
Die meisten Studien zu Niacinamide sind mechanistisch oder beobachtend statt RCTs, die einen klinischen Effekt messen — betrachte die Ergebnisse als vorläufig.
Die meiste Evidenz stammt aus gemischt-qualitativen randomisierten Studien, veröffentlicht 1995–2022 mit einer typischen Studiengröße von 50 Teilnehmenden.
Basierend auf 7 Studien · 5 RCTs · 301 Teilnehmende insgesamt
Konfidenz
Mittlere Konfidenz
Nach Outcome
Skin healthAntibiotikafreie Reduktion entzündlicher Akneläsionen (in einer Studie vergleichbar mit Clindamycin) · 8 weeks · Verbesserte Barrierefunktion (geringerer TEWL) und reduzierte Fahlheit/rote Flecken (kosmetisch) · 4-12 weeks · Moderate Reduktion feiner Linien aus einer industriegesponserten Split-Face-Studie (kosmetisch; der schwächste Teil der Evidenz) · 8-12 weeks
Überwiegend Mechanismus / Beobachtung4 Studien
Skin tone & pigmentationModerate Reduktion der Hyperpigmentierung und verbesserte Hautaufhellung/-klarheit (kosmetisch, kein gesundheitliches Ergebnis) · 4-12 weeks
Überwiegend Mechanismus / Beobachtung3 Studien
Safety profile
Zu wenige bewertete Studien2 Studien
Stetige Forschung
1 Studie in den letzten 5 Jahren
199520082022
1RCTn=50 · small study2005
Analyses of the data revealed a variety of significant skin appearance improvement effects for topical niacinamide: reductions in fine lines and wrinkles, hyperpigmented spots, red blotchiness, and skin sallowness (yellowing).
Bissett DL, Oblong JE, Berge CA. · Dermatol Surg (2005)
Double-blind, left-right randomized split-face design: 5% niacinamide vs vehicle applied twice daily for 12 weeks in 50 white women with facial photoaging
Significant improvements vs vehicle in fine lines/wrinkles, hyperpigmented spots, red blotchiness, and yellowing (sallowness)
Elasticity improved by cutometry; well tolerated. Foundational facial-aging cosmetic trial (Procter & Gamble)
In the clinical studies, niacinamide significantly decreased hyperpigmentation and increased skin lightness compared with vehicle alone after 4 weeks of use.
Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, Greatens A, Hillebrand GG, Bissett DL, Boissy RE. · Br J Dermatol (2002)
Paired clinical trial: 18 subjects with hyperpigmentation used 5% niacinamide vs vehicle moisturizer (plus a separate facial-tanning arm)
5% niacinamide significantly reduced hyperpigmentation and increased skin lightness vs vehicle by 4 weeks
Mechanistically, niacinamide gave 35-68% inhibition of melanosome transfer in coculture but had no effect on tyrosinase or melanocyte melanogenesis
Split-face RCT in 27 melasma patients: 4% niacinamide vs 4% hydroquinone (HQ) for 8 weeks, both with sunscreen
Both sides improved with no significant colorimetric difference, but good-to-excellent response was lower with niacinamide (44%) than HQ (55%)
Niacinamide had fewer side effects (18% vs 29% with HQ) and reduced mast-cell infiltrate and solar elastosis histologically — the key counter-evidence positioning it as a better-tolerated but slightly weaker alternative
After 8 weeks, both treatments produced comparable (P = 0.19) beneficial results in the Physician's Global Evaluation of Inflammatory Acne; 82% of the patients treated with nicotinamide gel and 68% treated with clindamycin gel were improved.
Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK. · Int J Dermatol (1995)
Double-blind RCT: 76 patients with moderate inflammatory acne randomized to 4% nicotinamide gel (n=38) vs 1% clindamycin gel (n=38), twice daily for 8 weeks
Comparable global improvement (82% nicotinamide vs 68% clindamycin, P=0.19) with no significant difference
Supports topical niacinamide as an antibiotic-free acne option of comparable efficacy to clindamycin
Evidence has shown ascorbic acid, azelaic acid, glycolic acid, kojic acid, salicylic acid, and niacinamide to be effective as adjuvant therapies with minimal side effects.
González-Molina V, Martí-Pineda A, González N. · J Clin Aesthet Dermatol (2022)
PRISMA systematic review of topical melasma agents: 348 studies screened, 80 met inclusion criteria
Niacinamide is classified as an effective adjuvant therapy with minimal side effects
Triple-combination therapy and hydroquinone remain the strongest-evidence, gold-standard treatments — niacinamide is positioned as adjuvant, not first-line; reviewers note small samples and a lack of large, long-term trials
6RCTn=130 · medium study2006
The 2% niacinamide treated group demonstrated significantly lowered SER after 2 and 4 weeks of application.
Draelos ZD, Matsubara A, Smiles K. · J Cosmet Laser Ther (2006)
Two trials: a double-blind placebo-controlled study in 100 Japanese subjects (4 weeks) and a 30-subject Caucasian split-face study (6 weeks)
In Japanese subjects, 2% niacinamide significantly lowered sebum excretion rate (SER) at 2 and 4 weeks vs placebo
In Caucasian subjects, casual sebum levels fell but SER did not — the effect was population/measure dependent and modest
Topical application of nicotinamide increased ceramide and free fatty acid levels in the stratum corneum, and decreased transepidermal water loss in dry skin.
Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. · Br J Dermatol (2000)
In cultured human keratinocytes, nicotinamide increased ceramide biosynthesis 4.1-5.5-fold and other barrier lipids, via upregulation of serine palmitoyltransferase
Topical application in vivo increased stratum-corneum ceramide and free fatty acid and decreased transepidermal water loss (TEWL) in dry skin
Foundational mechanism for niacinamide's barrier / anti-TEWL effect (in-vitro plus a small in-vivo component)